796362050	796362050	CD	B-NP	O
|	|	NN	I-NP	O
BH	BH	NN	I-NP	O
|	|	NN	I-NP	O
34715907	34715907	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
886814	886814	CD	B-NP	O
|	|	CC	I-NP	O
3/11/1991	3/11/1991	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Summary	Summary	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
3/11/1991	3/11/1991	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
7/30/1992	7/30/1992	CD	B-NP	O
DIAGNOSES	DIAGNOSES	NNS	I-NP	O
:	:	:	O	O
STATUS	STATUS	NN	B-NP	O
POST	POST	NN	I-NP	O
CARDIAC	CARDIAC	NN	I-NP	O
TRANSPLANT	TRANSPLANT	NN	I-NP	O
ON	ON	NN	I-NP	O
26	26	CD	I-NP	O
of	of	IN	B-PP	O
August	August	NNP	B-NP	O
AORTIC	AORTIC	NNP	I-NP	O
DISSECTION	DISSECTION	NNP	I-NP	O
.	.	.	O	O

NON-INSULIN-DEPENDENT	NON-INSULIN-DEPENDENT	JJ	B-NP	O
DIABETES	DIABETES	NNS	I-NP	O
MELLITUS	MELLITUS	NNS	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
TOBACCO	TOBACCO	NN	B-NP	O
ABUSE	ABUSE	NN	I-NP	O
IN	IN	IN	B-PP	O
THE	THE	DT	B-NP	O
PAST	PAST	NN	I-NP	B-DNA
.	.	.	O	O

HEPATITIS-C	HEPATITIS-C	NN	B-NP	B-protein
ANTIBODY	ANTIBODY	NN	I-NP	I-protein
POSITIVE	POSITIVE	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
51	51	CD	I-NP	O
year	year	NN	I-NP	O
old	old	JJ	I-NP	O
gentleman	gentleman	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
with	with	IN	B-PP	O
myocardial	myocardial	JJ	B-NP	O
infarction	infarction	NN	I-NP	O
in	in	IN	B-PP	O
1977	1977	CD	B-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
bypass	bypass	IN	B-PP	O
grafting	graft	VBG	B-VP	O
in	in	IN	B-PP	O
1977	1977	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
myocardial	myocardial	JJ	B-NP	O
infarction	infarction	NN	I-NP	O
in	in	IN	B-PP	O
1985	1985	CD	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
redo	redo	NN	B-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
bypass	bypass	IN	B-PP	O
grafting	graft	VBG	B-VP	O
at	at	IN	B-PP	O
Oua	Oua	NNP	B-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
,	,	,	O	O
complicated	complicate	VBN	B-VP	O
by	by	IN	B-PP	O
cardiogenic	cardiogenic	JJ	B-NP	O
shock	shock	NN	I-NP	O
,	,	,	O	O
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
intra-aortic	intra-aortic	JJ	I-NP	O
balloon	balloon	NN	I-NP	O
pump	pump	NN	I-NP	O
in	in	IN	B-PP	O
1985	1985	CD	B-NP	O
.	.	.	O	O

Since	Since	IN	B-PP	O
24	24	CD	B-NP	O
of	of	IN	B-PP	O
November	November	NNP	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
reported	report	VBD	B-VP	O
recurrent	recurrent	JJ	B-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
with	with	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
variable	variable	JJ	I-NP	O
bundle	bundle	NN	I-NP	O
branch	branch	NN	I-NP	O
block	block	NN	I-NP	O
requiring	require	VBG	B-VP	O
pacer	pacer	NN	B-NP	O
placement	placement	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
DDD	DDD	NN	I-NP	B-DNA
pacer	pacer	NN	I-NP	I-DNA
in	in	IN	B-PP	O
1990	1990	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
electrophysiologic	electrophysiologic	JJ	I-NP	O
study	study	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
ventricular	ventricular	JJ	B-NP	O
tachycardia	tachycardia	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
1	1	CD	B-NP	O
of	of	IN	B-PP	O
January	January	NNP	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
reported	report	VBN	B-VP	O
to	to	TO	B-PP	O
Hobrook	Hobrook	NNP	B-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
with	with	IN	B-PP	O
severe	severe	JJ	B-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
Mi	Mi	NNP	B-NP	O
Hospital	Hospital	NNP	I-NP	O
after	after	IN	B-PP	O
treatment	treatment	NN	B-NP	O
for	for	IN	B-PP	O
transplant	transplant	NN	B-NP	O
evaluation	evaluation	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
Tiesi	Tiesi	NNP	B-NP	O
Hospital	Hospital	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
on	on	IN	B-PP	O
3	3	CD	B-NP	O
of	of	IN	B-PP	O
March	March	NNP	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
work-up	work-up	NN	I-NP	O
included	include	VBD	B-VP	O
an	an	DT	B-NP	O
exercise	exercise	NN	I-NP	O
tolerance	tolerance	NN	I-NP	O
test	test	NN	I-NP	O
with	with	IN	B-PP	O
oxygen	oxygen	NN	B-NP	O
uptake	uptake	NN	I-NP	O
of	of	IN	B-PP	O
11.1	11.1	CD	B-NP	O
milliliters	milliliter	NNS	I-NP	O
per	per	IN	B-PP	O
kilogram	kilogram	NN	B-NP	O
per	per	IN	B-PP	O
minute	minute	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
catheterization	catheterization	NN	I-NP	O
showing	show	VBG	B-VP	O
an	an	DT	B-NP	O
essentially	essentially	RB	I-NP	O
open	open	JJ	I-NP	O
left	left	JJ	I-NP	O
internal	internal	JJ	I-NP	O
mammary	mammary	JJ	I-NP	O
artery	artery	NN	I-NP	O
with	with	IN	B-PP	O
saphenous	saphenous	JJ	B-NP	O
vein	vein	NN	I-NP	O
grafts	graft	NNS	I-NP	O
and	and	CC	O	O
occluded	occlude	VBD	B-VP	O
native	native	JJ	B-NP	O
vessels	vessel	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
right	right	JJ	I-NP	O
atrial	atrial	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
10	10	CD	B-NP	O
,	,	,	O	O
pulmonary	pulmonary	JJ	B-NP	O
artery	artery	NN	I-NP	O
pressure	pressure	NN	I-NP	O
54/28/30	54/28/30	CD	I-NP	O
,	,	,	O	O
pulmonary	pulmonary	JJ	B-NP	O
capillary	capillary	JJ	I-NP	O
wedge	wedge	NN	I-NP	O
pressure	pressure	NN	I-NP	O
36	36	CD	I-NP	O
,	,	,	O	O
cardiac	cardiac	JJ	B-NP	O
output	output	NN	I-NP	O
3.6	3.6	CD	I-NP	O
,	,	,	O	O
cardiac	cardiac	JJ	B-NP	B-protein
index	index	NN	I-NP	I-protein
2	2	CD	B-NP	I-protein
,	,	,	O	O
PVR	PVR	NN	B-NP	B-DNA
44	44	CD	I-NP	I-DNA
,	,	,	O	O
SVR	SVR	NN	B-NP	O
1440	1440	CD	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
severely	severely	RB	B-NP	O
decreased	decrease	VBN	I-NP	O
ejection	ejection	NN	I-NP	O
of	of	IN	B-PP	O
around	around	IN	B-NP	O
15	15	CD	I-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
mitral	mitral	JJ	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
.	.	.	O	O

Other	Other	JJ	B-NP	O
issues	issue	NNS	I-NP	O
included	include	VBD	B-VP	O
a	a	DT	B-NP	O
positive	positive	JJ	I-NP	O
tobacco	tobacco	NN	I-NP	O
history	history	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
moderately	moderately	RB	I-NP	O
decreased	decrease	VBN	I-NP	O
FEV-1	FEV-1	NN	I-NP	O
of	of	IN	B-PP	O
2.2	2.2	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
also	also	RB	B-ADVP	O
hepatitis-C	hepatitis-C	NN	B-NP	B-protein
antibody	antibody	NN	I-NP	I-protein
positivity	positivity	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
went	go	VBD	B-VP	O
home	home	NN	B-ADVP	O
after	after	IN	B-PP	O
evaluation	evaluation	NN	B-NP	O
for	for	IN	B-PP	O
2	2	CD	B-NP	O
weeks	week	NNS	I-NP	O
and	and	CC	O	O
did	do	VBD	B-VP	O
well	well	RB	B-ADVP	O
without	without	IN	B-PP	O
fever	fever	NN	B-NP	O
or	or	CC	I-NP	O
chills	chill	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
some	some	DT	B-NP	O
constipation	constipation	NN	I-NP	O
.	.	.	O	O

For	For	IN	B-PP	O
2	2	CD	B-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
some	some	DT	B-NP	O
increased	increase	VBN	I-NP	O
cough	cough	NN	I-NP	O
when	when	WRB	B-ADVP	O
lying	lie	VBG	B-VP	O
down	down	RB	B-ADJP	O
similar	similar	JJ	I-ADJP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
previous	previous	JJ	I-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
readmitted	readmitte	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
night	night	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
transplantation	transplantation	NN	B-NP	O
on	on	IN	B-PP	O
9	9	CD	B-NP	O
of	of	IN	B-PP	O
September	September	NNP	B-NP	O
,	,	,	O	O
for	for	IN	B-PP	O
increasing	increase	VBG	B-VP	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
and	and	CC	O	O
Dobutamine	Dobutamine	NN	B-NP	O
treatment	treatment	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
was	be	VBD	B-VP	O
as	as	RB	I-VP	O
stated	state	VBN	I-VP	O
above	above	RB	B-ADVP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
known	know	VBN	I-NP	O
drug	drug	NN	I-NP	O
allergies	allergy	NNS	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
25-pack-year	25-pack-year	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
tobacco	tobacco	NN	B-NP	O
,	,	,	O	O
none	none	NN	B-NP	O
since	since	IN	B-PP	O
1977	1977	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
4	4	CD	B-NP	O
children	child	NNS	I-NP	O
,	,	,	O	O
married	marry	VBD	B-VP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	VBP	B-VP	O
ADMISSION	ADMISSION	NN	B-NP	O
on	on	IN	B-PP	O
transfer	transfer	NN	B-NP	O
included	include	VBD	B-VP	O
digoxin	digoxin	NN	B-NP	O
.25	.25	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
each	each	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Pepcid	Pepcid	NN	B-NP	O
20	20	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
captopril	captopril	NN	B-NP	O
25	25	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
3	3	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Lasix	Lasix	NN	B-NP	O
80	80	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Ecotrin	Ecotrin	NN	B-NP	B-protein
1	1	CD	I-NP	I-protein
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
each	each	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Coumadin	Coumadin	NN	B-NP	O
,	,	,	O	O
Dobutamine	Dobutamine	NN	B-NP	O
drip	drip	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
somewhat	somewhat	RB	I-NP	O
cachectic	cachectic	JJ	I-NP	O
male	male	JJ	I-NP	O
,	,	,	I-NP	O
comfortable	comfortable	JJ	I-NP	O
with	with	IN	B-PP	O
oxygen	oxygen	NN	B-NP	O
.	.	.	O	O

Head	Head	RB	B-ADVP	O
,	,	,	O	O
eyes	eye	NNS	B-NP	O
,	,	,	O	O
ears	ear	NNS	B-NP	O
,	,	,	O	O
nose	nose	NN	B-NP	O
and	and	CC	I-NP	O
throat	throat	NN	I-NP	O
examination	examination	NN	I-NP	O
was	be	VBD	B-VP	O
benign	benign	JJ	B-ADJP	O
.	.	.	O	O

Neck	Neck	NN	B-NP	O
was	be	VBD	B-VP	O
supple	supple	NN	B-NP	O
without	without	IN	B-PP	O
adenopathy	adenopathy	NN	B-NP	O
.	.	.	O	O

Lungs	Lung	NNS	B-NP	O
were	be	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
tops	top	NNS	I-NP	O
with	with	IN	B-PP	O
bibasilar	bibasilar	JJ	B-NP	O
crackles	crackle	NNS	I-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-NP	O
examination	examination	NN	I-NP	O
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
S1	S1	NN	B-NP	B-protein
,	,	,	O	O
S2	S2	NN	B-NP	B-protein
and	and	CC	I-NP	O
S3	S3	NN	I-NP	B-protein
,	,	,	O	O
no	no	DT	B-NP	O
S4	S4	NN	I-NP	B-protein
,	,	,	I-NP	O
murmur	murmur	NN	I-NP	O
or	or	CC	I-NP	O
rub	rub	NN	I-NP	B-protein
.	.	.	O	O

Abdominal	Abdominal	JJ	B-NP	O
examination	examination	NN	I-NP	O
was	be	VBD	B-VP	O
benign	benign	JJ	B-ADJP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

Rectal	Rectal	JJ	B-NP	O
examination	examination	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
guaiac	guaiac	JJ	B-NP	O
negative	negative	JJ	I-NP	O
stool	stool	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
mass	mass	NN	I-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
laboratory	laboratory	NN	B-NP	O
values	value	NNS	I-NP	O
were	be	VBD	B-VP	O
essentially	essentially	RB	B-ADJP	O
normal	normal	JJ	I-ADJP	O
,	,	,	O	O
except	except	IN	B-PP	O
for	for	IN	B-PP	O
hyperglycemia	hyperglycemia	NN	B-NP	O
,	,	,	O	O
mildly	mildly	RB	B-ADVP	O
increased	increase	VBD	B-VP	O
liver	liver	NN	B-NP	O
function	function	NN	I-NP	O
tests	test	NNS	I-NP	O
and	and	CC	O	O
creatinine	creatinine	NN	B-NP	B-protein
1.1	1.1	CD	I-NP	I-protein
.	.	.	O	O

On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
urea	urea	NN	I-NP	O
nitrogen	nitrogen	NN	I-NP	O
was	be	VBD	B-VP	O
18	18	CD	B-NP	O
,	,	,	O	O
creatinine	creatinine	NN	B-NP	B-protein
.9	.9	CD	I-NP	I-protein
,	,	,	O	O
glucose	glucose	NN	B-NP	B-protein
176	176	CD	I-NP	I-protein
,	,	,	O	O
sodium	sodium	NN	B-NP	O
137	137	CD	I-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
4.1	4.1	CD	I-NP	O
,	,	,	O	O
prothrombin	prothrombin	NN	B-NP	B-protein
time	time	NN	I-NP	I-protein
13.1	13.1	CD	B-NP	I-protein
,	,	,	O	O
partial	partial	JJ	B-NP	O
thromboplastin	thromboplastin	NN	I-NP	O
time	time	NN	I-NP	O
29	29	CD	B-NP	O
,	,	,	O	O
calcium	calcium	NN	B-NP	O
8.5	8.5	CD	I-NP	O
,	,	,	O	O
albumin	albumin	NN	B-NP	B-protein
3.7	3.7	CD	I-NP	I-protein
,	,	,	O	O
magnesium	magnesium	NN	B-NP	O
2	2	CD	I-NP	O
,	,	,	O	O
ALT	ALT	NN	B-NP	O
17	17	CD	I-NP	O
,	,	,	O	O
alkaline	alkaline	NN	B-NP	O
phosphatase	phosphatase	NN	I-NP	O
155	155	CD	I-NP	O
,	,	,	O	O
total	total	JJ	B-NP	O
bilirubin	bilirubin	NN	I-NP	O
1.1	1.1	CD	I-NP	O
.	.	.	O	O

Urinalysis	Urinalysis	NN	B-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Hematocrit	Hematocrit	NN	B-NP	B-protein
was	be	VBD	B-VP	I-protein
38.8	38.8	CD	B-NP	I-protein
,	,	,	O	O
platelets	platelet	NNS	B-NP	B-cell_type
199	199	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
,	,	,	O	O
white	white	JJ	B-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
8.3	8.3	CD	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
electrocardiogram	electrocardiogram	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
AV	AV	NN	B-NP	O
pacing	pacing	NN	I-NP	O
at	at	IN	B-PP	O
90	90	CD	B-NP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
showed	show	VBD	B-VP	O
cardiomegaly	cardiomegaly	RB	B-ADVP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
pacer	pacer	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
wires	wire	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
ventricle	ventricle	NN	I-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
obtained	obtain	VBN	B-VP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
transplantation	transplantation	NN	B-NP	O
revealed	reveal	VBD	B-VP	O
right	right	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
10	10	CD	I-NP	O
,	,	,	O	O
pulmonary	pulmonary	JJ	B-NP	O
artery	artery	NN	I-NP	O
54/28/38	54/28/38	CD	I-NP	O
,	,	,	O	O
pulmonary	pulmonary	JJ	B-NP	O
capillary	capillary	JJ	I-NP	O
wedge	wedge	NN	I-NP	O
pressure	pressure	NN	I-NP	O
36	36	CD	I-NP	O
,	,	,	O	O
cardiac	cardiac	JJ	B-NP	O
output	output	NN	I-NP	O
3.6	3.6	CD	I-NP	O
,	,	,	O	O
cardiac	cardiac	JJ	B-NP	B-protein
index	index	NN	I-NP	I-protein
2	2	CD	B-NP	I-protein
,	,	,	O	O
PVR	PVR	NN	B-NP	B-DNA
44	44	CD	I-NP	I-DNA
,	,	,	O	O
SVR	SVR	NN	B-NP	O
1440	1440	CD	I-NP	O
,	,	,	O	O
ejection	ejection	NN	B-NP	O
fraction	fraction	NN	I-NP	O
15	15	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
mitral	mitral	JJ	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
operating	operating	NN	I-NP	O
room	room	NN	I-NP	O
on	on	IN	B-PP	O
15	15	CD	B-NP	O
of	of	IN	B-PP	O
November	November	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
received	receive	VBD	B-VP	O
an	an	DT	B-NP	O
orthotopic	orthotopic	JJ	I-NP	O
heart	heart	NN	I-NP	O
transplant	transplant	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
complicated	complicate	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
descending	descend	VBG	I-NP	O
aortic	aortic	JJ	I-NP	O
dissection	dissection	NN	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
iliac	iliac	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
subclavian	subclavian	JJ	I-NP	O
vein	vein	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
femoral	femoral	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
,	,	,	O	O
because	because	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
had	have	VBN	I-VP	O
2	2	CD	B-NP	O
previous	previous	JJ	I-NP	O
bypasses	bypass	NNS	I-NP	O
and	and	CC	O	O
would	would	MD	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
tolerated	tolerate	VBN	I-VP	O
aortic	aortic	JJ	B-NP	O
bypass	bypass	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
well	well	RB	B-ADVP	O
postoperatively	postoperatively	RB	B-ADVP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
Cyclosporine-A	Cyclosporine-A	NN	B-NP	O
and	and	CC	I-NP	O
prednisone	prednisone	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
weaned	wean	VBN	I-VP	O
off	off	IN	B-PP	O
the	the	DT	B-NP	O
ventilator	ventilator	NN	I-NP	O
and	and	CC	I-NP	O
Dobutamine	Dobutamine	NN	I-NP	O
and	and	CC	O	O
diuresed	diurese	VBN	B-VP	O
without	without	IN	B-PP	O
difficulty	difficulty	NN	B-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
one	one	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
preoperative	preoperative	JJ	I-NP	O
blood	blood	NN	I-NP	O
cultures	culture	NNS	I-NP	O
grew	grow	VBD	B-VP	O
out	out	RP	B-PRT	O
Clostridium	Clostridium	NN	B-NP	O
perfringens	perfringen	NNS	I-NP	O
.	.	.	O	O

Three	Three	CD	B-NP	O
subsequent	subsequent	JJ	I-NP	O
blood	blood	NN	I-NP	O
cultures	culture	NNS	I-NP	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
.	.	.	O	O

An	An	DT	B-NP	O
Infectious	Infectious	NNP	I-NP	O
Disease	Disease	NNP	I-NP	O
Service	Service	NNP	I-NP	O
consultation	consultation	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
that	that	IN	B-SBAR	O
intravenous	intravenous	JJ	B-NP	B-protein
penicillin	penicillin	NN	I-NP	I-protein
for	for	IN	B-PP	O
10	10	CD	B-NP	O
to	to	TO	I-NP	O
14	14	CD	I-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
30	30	CD	B-NP	O
million	million	CD	I-NP	O
units	unit	NNS	I-NP	O
every	every	DT	B-NP	O
4	4	CD	I-NP	O
hours	hour	NNS	I-NP	O
,	,	,	O	O
would	would	MD	B-VP	O
be	be	VB	I-VP	O
warranted	warrant	VBN	I-VP	O
given	give	VBN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
underlying	underlie	VBG	I-NP	O
immunosuppression	immunosuppression	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
underwent	undergo	VBD	B-VP	O
right	right	JJ	B-NP	O
ventricular	ventricular	JJ	I-NP	O
biopsies	biopsy	NNS	I-NP	O
according	accord	VBG	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
protocol	protocol	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
rejection	rejection	NN	B-NP	O
on	on	IN	B-PP	O
any	any	DT	B-NP	O
biopsies	biopsy	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
underwent	undergo	VBD	B-VP	O
magnetic	magnetic	JJ	B-NP	O
resonance	resonance	NN	I-NP	O
imaging	imaging	NN	I-NP	O
evaluation	evaluation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
aortic	aortic	JJ	I-NP	O
dissection	dissection	NN	I-NP	O
on	on	IN	B-PP	O
11	11	CD	B-NP	O
of	of	IN	B-PP	O
February	February	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
then	then	RB	B-ADJP	O
follow-up	follow-up	JJ	I-ADJP	O
on	on	IN	B-PP	O
10	10	CD	B-NP	O
of	of	IN	B-PP	O
March	March	NNP	B-NP	O
These	These	DT	O	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
type-B	type-B	NN	I-NP	O
dissection	dissection	NN	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
iliac	iliac	JJ	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
subclavian	subclavian	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
ascending	ascend	VBG	I-NP	O
aorta	aorta	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
involved	involve	VBN	I-VP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
flow	flow	NN	B-NP	O
in	in	IN	B-PP	O
both	both	CC	B-NP	O
the	the	DT	I-NP	O
true	true	JJ	I-NP	O
and	and	CC	I-NP	O
false	false	JJ	I-NP	O
lumen	lumen	NN	I-NP	O
on	on	IN	B-PP	O
both	both	DT	B-NP	O
tests	test	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
renal	renal	JJ	I-NP	O
,	,	,	I-NP	O
SMA	SMA	NN	I-NP	B-protein
and	and	CC	I-NP	O
ciliac	ciliac	JJ	I-NP	O
arteries	artery	NNS	I-NP	O
were	be	VBD	B-VP	O
all	all	DT	O	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

An	An	DT	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
on	on	IN	B-PP	O
11	11	CD	B-NP	O
of	of	IN	B-PP	O
February	February	NNP	B-NP	O
,	,	,	O	O
revealed	reveal	VBD	B-VP	O
good	good	JJ	B-NP	O
left	left	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
function	function	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
small	small	JJ	I-NP	O
amount	amount	NN	I-NP	O
of	of	IN	B-PP	O
mitral	mitral	JJ	B-NP	O
regurgitation	regurgitation	NN	I-NP	O
,	,	,	O	O
some	some	DT	B-NP	O
increased	increase	VBN	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
pressures	pressure	NNS	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
dissection	dissection	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
aorta	aorta	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
underwent	undergo	VBD	B-VP	O
abdominal	abdominal	JJ	B-NP	O
computerized	computerize	VBN	I-NP	O
tomography	tomography	NN	I-NP	O
scan	scan	NN	I-NP	O
to	to	TO	B-VP	O
rule	rule	VB	I-VP	O
out	out	RP	B-PRT	O
any	any	DT	B-NP	O
occult	occult	JJ	I-NP	O
source	source	NN	I-NP	O
of	of	IN	B-PP	O
abscess	abscess	NN	B-NP	O
which	which	WDT	B-NP	O
would	would	MD	B-VP	O
be	be	VB	I-VP	O
responsible	responsible	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
Clostridium	Clostridium	NN	I-NP	O
bacteremia	bacteremia	NN	I-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
recommended	recommend	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
gastroenterology	gastroenterology	NN	I-NP	O
consultant	consultant	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
such	such	JJ	I-NP	O
source	source	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
controlled	control	VBN	I-VP	O
with	with	IN	B-PP	O
Nifedipine	Nifedipine	NN	B-NP	O
3	3	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
30	30	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
,	,	,	O	O
until	until	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
reached	reach	VBD	B-VP	O
the	the	DT	B-NP	O
expected	expect	VBN	I-NP	O
postoperative	postoperative	JJ	I-NP	O
denervated	denervate	VBN	I-NP	O
tachycardia	tachycardia	NN	I-NP	O
.	.	.	O	O

After	After	IN	B-PP	O
this	this	DT	B-NP	O
point	point	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
beta	beta	NN	I-NP	O
blocker	blocker	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
form	form	NN	I-NP	O
of	of	IN	B-PP	O
atenolol	atenolol	NN	B-NP	O
25	25	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
each	each	DT	B-NP	O
day	day	NN	I-NP	O
was	be	VBD	B-VP	O
added	add	VBN	I-VP	O
to	to	TO	I-VP	O
decrease	decrease	VB	I-VP	O
force	force	NN	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
wall	wall	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
dissection	dissection	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Cardiology	Cardiology	NNP	I-NP	O
Service	Service	NNP	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
Cardiothoracic	Cardiothoracic	NNP	I-NP	O
Surgery	Surgery	NNP	I-NP	O
Service	Service	NNP	I-NP	O
on	on	IN	B-PP	O
11	11	CD	B-NP	O
of	of	IN	B-PP	O
February	February	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
did	do	VBD	B-VP	O
well	well	RB	B-ADVP	O
.	.	.	O	O

Adjustments	Adjustment	NNS	B-NP	O
were	be	VBD	B-VP	O
made	make	VBN	I-VP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
Cyclosporine	Cyclosporine	NN	I-NP	O
dose	dose	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
tried	try	VBN	I-VP	O
on	on	IN	B-PP	O
some	some	DT	B-NP	O
NPH	NPH	NN	I-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
for	for	IN	B-PP	O
hyperglycemia	hyperglycemia	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
eventually	eventually	RB	B-ADVP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
prednisone	prednisone	NN	I-NP	O
taper	taper	NN	I-NP	O
had	have	VBD	B-VP	O
good	good	JJ	B-NP	O
blood	blood	NN	I-NP	O
sugars	sugar	NNS	I-NP	O
on	on	IN	B-PP	O
Glyburide	Glyburide	NN	B-NP	O
2.5	2.5	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
each	each	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
goal	goal	NN	I-NP	O
was	be	VBD	B-VP	O
set	set	VBN	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
kept	keep	VBN	I-VP	O
at	at	IN	B-PP	O
all	all	DT	B-NP	O
times	time	NNS	I-NP	O
below	below	IN	B-PP	O
140	140	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
most	most	JJS	I-NP	O
part	part	NN	I-NP	O
achieved	achieve	VBD	B-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
anemic	anemic	JJ	B-ADJP	O
during	during	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
postoperatively	postoperatively	RB	B-ADVP	O
gradually	gradually	RB	B-ADVP	O
his	his	PRP$	B-NP	O
red	red	JJ	I-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
increased	increase	VBD	B-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
iron	iron	NN	B-NP	O
sulfate	sulfate	NN	I-NP	O
to	to	TO	B-VP	O
assist	assist	VB	I-VP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
hematologic	hematologic	JJ	I-NP	O
recovery	recovery	NN	I-NP	O
.	.	.	O	O

B12	B12	NN	B-NP	B-protein
and	and	CC	I-NP	O
folate	folate	NN	I-NP	O
levels	level	NNS	I-NP	O
were	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
despite	despite	IN	B-PP	O
polys	poly	NNS	B-NP	O
on	on	IN	B-PP	O
stain	stain	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
chest	ch	JJS	I-NP	O
tube	tube	NN	I-NP	O
wounds	wound	NNS	I-NP	O
were	be	VBD	B-VP	O
cultured	culture	VBN	I-VP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
postoperative	postoperative	JJ	I-NP	O
course	course	NN	I-NP	O
and	and	CC	O	O
grew	grow	VBD	B-VP	O
normal	normal	JJ	B-NP	O
skin	skin	NN	I-NP	O
flora	flora	NN	I-NP	O
.	.	.	O	O

They	They	PRP	B-NP	O
were	be	VBD	B-VP	O
packed	pack	VBN	I-VP	O
with	with	IN	B-PP	O
wicks	wick	NNS	B-NP	O
as	as	IN	B-PP	O
necessary	necessary	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
left	left	JJ	I-NP	O
groin	groin	NN	I-NP	O
lymph	lymph	NN	I-NP	O
area	area	NN	I-NP	O
drained	drain	VBD	B-VP	O
clear	clear	JJ	B-NP	O
fluid	fluid	NN	I-NP	O
and	and	CC	O	O
persisted	persist	VBD	B-VP	O
,	,	,	O	O
but	but	CC	O	O
had	have	VBD	B-VP	O
decreased	decrease	VBN	I-VP	O
substantially	substantially	RB	B-ADJP	O
prior	prior	JJ	I-ADJP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
evaluated	evaluate	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
Psychiatry	Psychiatry	NNP	I-NP	O
Service	Service	NNP	I-NP	O
for	for	IN	B-PP	O
some	some	DT	B-NP	O
features	feature	NNS	I-NP	O
of	of	IN	B-PP	O
hypomania	hypomania	NN	B-NP	O
on	on	IN	B-PP	O
17	17	CD	B-NP	O
of	of	IN	B-PP	O
May	May	NNP	B-NP	O
They	They	NNP	I-NP	O
recommended	recommend	VBD	B-VP	O
Valium	Valium	NNP	B-NP	O
5	5	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
3	3	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
to	to	TO	B-VP	O
counter	counter	VB	I-VP	O
the	the	DT	B-NP	O
steroid-induced	steroid-induced	JJ	I-NP	O
hypomania	hypomania	NN	I-NP	O
.	.	.	O	O

Physical	Physical	NNP	B-NP	O
Therapy	Therapy	NNP	I-NP	O
Service	Service	NNP	I-NP	O
was	be	VBD	B-VP	O
active	active	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
ambulation	ambulation	NN	I-NP	O
and	and	CC	O	O
felt	feel	VBD	B-VP	O
comfortable	comfortable	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
would	would	MD	B-VP	O
be	be	VB	I-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
go	go	VB	I-VP	O
home	home	NN	B-NP	O
and	and	CC	I-NP	O
manage	manage	NN	I-NP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
own	own	JJ	I-NP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

COMPLICATIONS	COMPLICATIONS	NNS	B-NP	O
included	include	VBD	B-VP	O
aortic	aortic	JJ	B-NP	B-protein
dissection	dissection	NN	I-NP	I-protein
type	type	NN	I-NP	I-protein
B	B	NN	I-NP	I-protein
from	from	IN	B-PP	O
left	leave	VBN	B-VP	O
iliac	iliac	JJ	B-ADJP	O
to	to	TO	B-VP	O
left	left	VB	I-VP	O
subclavian	subclavian	JJ	B-ADJP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
were	be	VBD	B-VP	O
Cyclosporine-A	Cyclosporine-A	NN	B-NP	O
250	250	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Imuran	Imuran	NN	B-NP	O
50	50	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
each	each	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
prednisone	prednisone	NN	B-NP	O
25	25	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
each	each	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
atenolol	atenolol	NN	B-NP	O
75	75	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
each	each	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Glyburide	Glyburide	NN	B-NP	O
2.5	2.5	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
each	each	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Nifedipine	Nifedipine	NN	B-NP	O
30	30	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
4	4	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Septra-Double-Strength	Septra-Double-Strength	NN	B-NP	O
1	1	CD	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
every	every	DT	B-NP	O
other	other	JJ	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Nystatin	Nystatin	NN	B-NP	O
15	15	CD	I-NP	O
cc	cc	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
4	4	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
iron	iron	NN	B-NP	O
sulfate	sulfate	NN	I-NP	O
325	325	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
3	3	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Valium	Valium	NN	B-NP	O
2.5	2.5	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
3	3	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

CONDITION	CONDITION	NN	B-NP	O
ON	ON	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
was	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
a	a	DT	B-NP	O
low-saturated	low-saturated	JJ	I-NP	O
fat	fat	NN	I-NP	O
,	,	,	O	O
low-cholesterol	low-cholesterol	NN	B-NP	O
,	,	,	O	O
no-added-salt	no-added-salt	JJ	B-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
will	will	MD	B-VP	O
advance	advance	VB	I-VP	O
his	his	PRP$	B-NP	O
activity	activity	NN	I-NP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
visiting	visit	VBG	I-NP	O
nurse	nurse	NN	I-NP	O
daily	daily	RB	B-ADVP	O
until	until	IN	B-SBAR	O
he	he	PRP	B-NP	O
feels	feel	VBZ	B-VP	O
comfortable	comfortable	JJ	B-ADJP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
own	own	JJ	I-NP	O
care	care	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
visiting	visit	VBG	I-NP	O
nurse	nurse	NN	I-NP	O
will	will	MD	B-VP	O
assist	assist	VB	I-VP	O
in	in	IN	B-PP	O
wound	wound	JJ	B-NP	O
dressing	dress	VBG	I-NP	O
changes	change	NNS	I-NP	O
,	,	,	O	O
taking	take	VBG	B-VP	O
his	his	PRP$	B-NP	O
finger	finger	NN	I-NP	O
sticks	stick	VBZ	B-VP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
taking	take	VBG	B-VP	O
his	his	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
and	and	CC	O	O
notifying	notify	VBG	B-VP	O
physicians	physician	NNS	B-NP	O
for	for	IN	B-PP	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
140	140	CD	B-NP	O
.	.	.	O	O

They	They	PRP	B-NP	O
were	be	VBD	B-VP	O
to	to	TO	I-VP	O
check	check	VB	I-VP	O
differential	differential	JJ	B-NP	O
blood	blood	NN	I-NP	O
pressures	pressure	NNS	I-NP	O
between	between	IN	B-PP	O
right	right	JJ	B-NP	O
and	and	CC	I-NP	O
left	left	JJ	I-NP	O
arms	arm	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
also	also	RB	I-VP	O
receive	receive	VB	I-VP	O
physical	physical	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
assistance	assistance	NN	I-NP	O
to	to	TO	B-VP	O
continue	continue	VB	I-VP	O
his	his	PRP$	B-NP	O
progress	progress	NN	I-NP	O
in	in	IN	B-PP	O
ambulation	ambulation	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-PP	O
FOLLOW-UP	FOLLOW-UP	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
Cardiac	Cardiac	NNP	I-NP	O
Transplant	Transplant	NNP	I-NP	O
Clinic	Clinic	NNP	I-NP	O
on	on	IN	B-PP	O
28	28	CD	B-NP	O
of	of	IN	B-PP	O
November	November	NNP	B-NP	O
,	,	,	O	O
for	for	IN	B-PP	O
routine	routine	JJ	B-NP	O
FOLLOW-UP	FOLLOW-UP	NN	I-NP	O
.	.	.	O	O

CG507/0006	CG507/0006	NN	B-NP	O
STAN	STAN	NN	I-NP	O
O.	O.	NNP	I-NP	O
PUHRMAN	PUHRMAN	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
AD2	AD2	NNP	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
5/22/92	5/22/92	CD	B-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
8352	8352	CD	B-NP	O
Report	Report	NNP	I-NP	O
:	:	:	O	O
O6076U8	O6076U8	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
8/28/92	8/28/92	CD	B-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
ABRAHAM	ABRAHAM	NNP	B-NP	O
T.	T.	NNP	I-NP	O
SANTOSCOY	SANTOSCOY	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
cc	cc	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

DWAIN	DWAIN	NNP	B-NP	O
E.	E.	NNP	I-NP	O
VENECIA	VENECIA	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	B-protein
2	2	CD	I-NP	I-protein
.	.	.	O	O

SHELDON	SHELDON	NNP	B-NP	O
ROSELLE	ROSELLE	NNP	I-NP	O
,	,	,	O	O
M.D	M.D	NNP	B-NP	O
.	.	.	O	O

